[1]
2023. Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants. SKIN The Journal of Cutaneous Medicine. 7, 4 (Jul. 2023), s227. DOI:https://doi.org/10.25251/skin.7.supp.227.